Learning Objectives:
1. Describe neuroimaging biomarkers for diagnosis of parkinsonian disorders and for tracking disease progression
2. Describe clinical and research applications of molecular imaging in parkinsonian disorders
3. Discuss imaging methods for assessing target engagement in clinical trials and principles, application and pitfalls of ‘radiomics’ in complex data analysis